Chemokine C-C motif ligand 2 suppressed the growth of human brain astrocytes under Ischemic/hypoxic conditions via regulating ERK1/2 pathway

References

• Grysiewicz RA, Thomas K, Pandey DK. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin. 2008;26(4):871–95. doi:10.1016/j.ncl.2008.07.003.
   PubMed Web of Science ®Google Scholar
• GöTz T, Jan S, Martin KH, Fiebach JB, Jens F, Olivier ZW, Kruetzelmann A, Kucinski T, Rosenkranz M, Röther J, et al. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Stroke. 2007;38(2):313. doi:10.1161/01.STR.0000254565.51807.22.
   PubMed Web of Science ®Google Scholar
• Numis AL, Fox CK. Arterial ischemic stroke in children: risk factors and etiologies. Curr Neurol Neurosci Rep. 2014;14(1):422. doi:10.1007/s11910-013-0422-8.
   PubMed Web of Science ®Google Scholar
• Cekanaviciute E, Buckwalter MS. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases. Neurotherapeutics. 2016;13(4):685–701. doi:10.1007/s13311-016-0477-8.
   PubMed Web of Science ®Google Scholar
• Liu Z, Chopp M. Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke. Prog Neurobiol. 2016;144:103–20. doi:10.1016/j.pneurobio.2015.09.008.
   PubMed Web of Science ®Google Scholar
• Colombo E, Astrocytes: FC. Key regulators of neuroinflammation. Trends Immunol. 2016;37(9):608–20. doi:10.1016/j.it.2016.06.006.
   PubMed Web of Science ®Google Scholar
• Sims NR, Yew WP. Reactive astrogliosis in stroke: contributions of astrocytes to recovery of neurological function. Neurochem Int. 2017;107:S0197018616303874. doi:10.1016/j.neuint.2016.12.016.
   Web of Science ®Google Scholar
• Sofroniew MV. Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci. 2015;16(5):249–63. doi:10.1038/nrn3898.
   PubMed Web of Science ®Google Scholar
• Rhodes JK, Sharkey J, Andrews PJ. The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat. J Neurotrauma. 2009;26(4):507. doi:10.1089/neu.2008.0686.
   PubMed Web of Science ®Google Scholar
• Voorn P,VD, Tekstra J, Beelen RH, Tensen CP, Valk P,VD, Groot CJ,D. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Amjpathol. 1999;154(1):45–51.
   Google Scholar
• Li S, Pachter JS. Monocyte chemoattractant protein-1 alters expression of tight junction-associated proteins in brain microvascular endothelial cells. Microvasc Res. 2004;67(1):78–89. doi:10.1016/j.mvr.2003.07.001.
   PubMed Web of Science ®Google Scholar
• Kollar A. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE. J Neuroimmunol. 2010;229(1):180–91. doi:10.1016/j.jneuroim.2010.08.011.
   PubMed Web of Science ®Google Scholar
• He M, Dong H, Huang Y, Lu S, Zhang S, Qian Y, Jin W. Astrocyte-derived CCL2 is associated with M1 activation and recruitment of cultured microglial cells. Cell Physiol Biochem. 2016;38(3):859–70. doi:10.1159/000443040.
   PubMedGoogle Scholar
• Bauer D, Redmon N, Mazzio E, Taka E, Reuben JS, Day A, SadrudDin  S ,  FloresRozas H ,  Soliman KFA,  DarlingReed S. Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling. Faseb J 2015;75:117–26.
   Google Scholar
• Lin YC, Lin YC, Huang MY, Kuo PL, Wu CC, Lee MS, Hsieh -C-C, Kuo H-F, Kuo C-H, Tsai W-C, et al. Tumor necrosis factor-alpha inhibitors suppress CCL2 chemokine in monocytes via epigenetic modification. Mol Immunol. 2017;83:82–91.
   PubMed Web of Science ®Google Scholar
• Ren L, Wei C, Li K, Lu Z. LncRNA MALAT1 up-regulates VEGF-A and ANGPT2 to promote angiogenesis in brain microvascular endothelial cells against oxygen-glucose deprivation via targetting miR-145. Biosci Rep. 2019;39(3):BSR20180226. doi:10.1042/BSR20180226.
   PubMedGoogle Scholar
• Yin KJ, Deng Z, Huang HR, Hamblin M, Xie CQ, Zhang JF, Chen YE. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis. 2010;38(1):17–26. doi:10.1016/j.nbd.2009.12.021.
   PubMed Web of Science ®Google Scholar
• Bska IP, Wyrodek E, Kosacka M, Adamiak J. Apoptotic markers p53, Bcl-2 and Bax in Primary Lung Cancer. In Vivo (Brooklyn). 2006;20:599–604.
   Web of Science ®Google Scholar
• Liu PF, Hu YC, Kang BH, Tseng YK, Wu PC, Liang CC, Hou -Y-Y, Fu T-Y, Liou -H-H, Hsieh I-C, et al. Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma. PloS One. 2017;12(7):e0180620. doi:10.1371/journal.pone.0180620.
   PubMed Web of Science ®Google Scholar
• Roger VL, Go AS, Lloydjones DM, Benjamin EJ, Berry JD, Borden WB,  Bravata  DM , Dai SF , Ford ES , Fox  CS, Heart disease and stroke statistics–2012 update: a report from the American heart association. Circulation 2010;127:143–52.
   Google Scholar
• Guillamón-Vivancos T, Gómez-Pinedo U, Matías-Guiu J. Astrocytes in neurodegenerative diseases (I): function and molecular description. Neurología. 2015;30(2):119–29. doi:10.1016/j.nrl.2012.12.007.
   PubMed Web of Science ®Google Scholar
• Gleichman AJ, Carmichael ST. Astrocytic therapies for neuronal repair in stroke. Neurosci Lett. 2014;565(17):47–52. doi:10.1016/j.neulet.2013.10.055.
   PubMedGoogle Scholar
• Xu J, Dong H, Qian Q, Zhang X, Wang Y, Jin W, Qian Y. Astrocyte-derived CCL2 participates in surgery-induced cognitive dysfunction and neuroinflammation via evoking microglia activation. Behav Brain Res. 2017;332:145.
   PubMed Web of Science ®Google Scholar
• Maike H-R, Alexander W, Juliane M, Markus M, Stephan S, Carsten J, Kleinschmidt M, Cynis H, Kehlen A, Arendt T, et al. Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease. Acta Neuropathol. 2015;129(4):565–83. doi:10.1007/s00401-015-1395-2.
   PubMed Web of Science ®Google Scholar
• Yuri I, Yoichiro K, Kazuo K, Shinichiro U, Noriyuki S. Activated microglia in ischemic stroke penumbra upregulate MCP-1 and CCR2 expression in response to lysophosphatidylcholine derived from adjacent neurons and astrocytes. Neuropathology. 2015;35(3):209–23. doi:10.1111/neup.12182.
   PubMed Web of Science ®Google Scholar
• Amadeus G, Janet VE, Mian B, Ke YD, Ittner LM. ERK inhibition with PD184161 mitigates brain damage in a mouse model of stroke. J Neural Transm. 2014;121(5):543–47. doi:10.1007/s00702-013-1138-2.
   PubMed Web of Science ®Google Scholar
• Xiong W, Wu Y, Xian W, Song L, Shang Y. DAPK1-ERK signal mediates oxygen glucose deprivation reperfusion induced apoptosis in mouse N2a cells. J Neurol Sci. 2018;387:S0022510X18300030. doi:10.1016/j.jns.2018.01.003.
   Web of Science ®Google Scholar
• Xu L, Wang L, Wen Z, Wu L, Jiang Y, Yang L, Xiao L, Xie Y, Ma M, Zhu W, et al. Caveolin-1 is a checkpoint regulator in hypoxia-induced astrocyte apoptosis via Ras/Raf/ERK pathway. Am J Physiol Cell Physiol. 2016;310(11):ajpcell.00309.2015. doi:10.1152/ajpcell.00309.2015.
   Web of Science ®Google Scholar